2022 Training Program in Nervous System Tumors

October 18, 2021

The Massachusetts General Hospital, in conjunction with the Dana-Farber/Harvard Cancer Center, is pleased to offer a National Cancer Institute-sponsored, 2-year research/training fellowship in nervous system tumors.

Eligible applicants must be U.S. citizens or permanent U.S. residents, must have completed clinical training in neurology, neurosurgery, neuropathology, medical oncology, pediatric oncology or radiation oncology and must be eligible for HMS appointment at the Fellow or Instructor level. The program consists of 2 years of research experience as well as didactic training in clinical research methodology. Trainees are expected to devote at least 75% effort to research training. Trainees should engage in laboratory-based or clinical translational research on nervous system tumors under the guidance of an experienced mentor.

Applications are due by Monday, November 22, 2021 for the training period July 1, 2022 – June 30, 2024. Awardees will be notified by Monday, December 13, 2021. An application consists of 1) project description (2 pages maximum), 2) curriculum vitae (HMS format) and 3) three letters of recommendation (including one from the prospective research mentor).

Applications should be submitted as a single PDF via email to:

Leah Hesse, Ph.D.
K12 Program Administrator
lhesse@partners.org